Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) have received an average rating of "Moderate Buy" from the six ratings firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and five have given a buy r